β-Lapachone Exerts Hypnotic Effects via Adenosine A1 Receptor in Mice DOI Creative Commons
Do Hyun Lee,

Hye Jin Jee,

Yi-Sook Jung

et al.

Biomolecules & Therapeutics, Journal Year: 2024, Volume and Issue: 32(5), P. 531 - 539

Published: Aug. 21, 2024

Sleep is one of the most essential physiological phenomena for maintaining health.Sleep disturbances, such as insomnia, are often accompanied by psychiatric or physical conditions impaired attention, anxiety, and stress.Medication used to treat insomnia have concerns about potential side effects with long-term use, so interest in use alternative medicine increasing.In this study, we investigated hypnotic β-lapachone (β-Lap), a natural naphthoquinone compound, using pentobarbital-induced sleep test, immunohistochemistry, real-time PCR, western blot mice.Our results indicated that β-Lap exerts significant effect showing decrease onset latency an increase total time model.The c-Fos immunostaining showed decreased neuronal activity basal forebrain lateral hypothalamus, which wakefulness-promoting brain regions, while increasing ventrolateral preoptic nucleus, sleep-promoting region; all these were significantly abolished 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), adenosine A1 receptor (A1R) antagonist.Western analysis increased extracellular signalregulated kinase phosphorylation nuclear factor-kappa B translocation from cytoplasm nucleus; inhibited DPCPX.Additionally, mRNA levels A1R.Taken together, suggest effects, potentially through A1R.

Language: Английский

Advancing Precision: A Controllable Self-Synergistic Nanoplatform Initiating Pyroptosis-Based Immunogenic Cell Death Cascade for Targeted Tumor Therapy DOI

Weiji Qin,

Lei Qiao, Qian Wang

et al.

ACS Nano, Journal Year: 2024, Volume and Issue: 18(2), P. 1582 - 1598

Published: Jan. 3, 2024

Heterogeneity of the tumor microenvironment (TME) is primarily responsible for ineffective treatment and uncontrolled progression. Pyroptosis-based immunogenic cell death (ICD) therapy an ideal strategy to overcome TME heterogeneity obtain a satisfactory antitumor effect. However, efficiency current pyroptosis therapeutics, which mainly depends on single endogenous or exogenous stimulus, limited by intrinsic pathological features malignant cells. Thus, it necessary develop synergistic with high specificity modulability. Herein, nanoplatform constructed combining neutrophil camouflaging shell self-synergistic reactive oxygen species (ROS) supplier-loaded polymer. The covered membranes endow stealthy properties facilitate sufficient accumulation. Under laser irradiation, photosensitizer (indocyanine green) exogenously triggers ROS generation converts irradiation into heat upregulate NAD(P)H:quinone oxidoreductase 1, further catalyzes β-Lapachone self-produce ROS, resulting in amplified ICD outcomes. results confirm that continuously production not only eliminates primary but also concurrently enhances gasdermin E-mediated pyroptosis, initiates cascade, re-educates heterogeneous TME, promotes systemic immune response suppress distant tumors. Overall, this provides efficient durable method redesigning system targeted inhibition.

Language: Английский

Citations

15

Human NQO1 as a Selective Target for Anticancer Therapeutics and Tumor Imaging DOI Creative Commons

Azeem Khan,

Viswanath Arutla,

Kalkunte S. Srivenugopal

et al.

Cells, Journal Year: 2024, Volume and Issue: 13(15), P. 1272 - 1272

Published: July 29, 2024

Human NAD(P)H-quinone oxidoreductase1 (HNQO1) is a two-electron reductase antioxidant enzyme whose expression driven by the NRF2 transcription factor highly active in prooxidant milieu found human malignancies. The resulting abundance of NQO1 (up to 200-fold) cancers and barely detectable body tissues makes it selective marker neoplasms. can catalyze repeated futile redox cycling certain natural synthetic quinones their hydroxyquinones, consuming NADPH generating rapid bursts cytotoxic reactive oxygen species (ROS) H2O2. A greater level this quinone bioactivation due elevated content has been recognized as tumor-specific therapeutic strategy, which, however, not clinically exploited. We review here new activated NQO1, catalytic inhibitors, ensuing cell death mechanisms. Further, cancer-selective opened excellent opportunities for distinguishing cancer cells/tissues from normal counterparts. Given diagnostic, prognostic, importance, we others have engineered large number specific turn-on small molecule probes that remain latent but release intense fluorescence groups at near-infrared other wavelengths, following enzymatic cleavage cells tumor masses. This sensitive visualization/quantitation powerful imaging technology based on offers promise guided surgery, reagents suggest theranostic potential NQO1-targeted chemotherapy.

Language: Английский

Citations

5

Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells DOI Open Access
Jesús Calahorra, José L. Blaya-Cánovas,

Olivia Castellini-Pérez

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 174, P. 116439 - 116439

Published: March 21, 2024

Triple-negative breast cancer (TNBC) is characterised by its aggressiveness and resistance to chemotherapy, demanding the development of effective strategies against unique characteristics. Derived from lapacho tree bark, β-lapachone (β-LP) selectively targets cells with elevated levels detoxifying enzyme NQO1. Hydroxytyrosol (HT) a phenolic compound derived olive trees important anticancer properties that include inhibition stem (CSCs) metastatic features in TNBC, as well relevant antioxidant activities mechanisms such induction We aimed study whether these compounds could have synergistic activity TNBC possible role For this pourpose, we assessed impact β-LP (0.5 or 1.5 μM) HT (50 100 on five cell lines. demonstrated combination exhibits anti-proliferative, pro-apoptotic, cycle arrest effects several cells, including docetaxel-resistant cells. Additionally, it effectively inhibits self-renewal clonogenicity CSCs, modifying their aggressive phenotype. However, notable β-LP-HT does not appear be solely associated NQO1 protein ROS. RNA-Seq analysis revealed combination's linked strong endoplasmic reticulum stress apoptosis through unfolded response. In conclusion, study, how offer an affordable, safe, approach TNBC.

Language: Английский

Citations

4

Stimuli-Responsive Prodrugs with Self-Immolative Linker for Improved Cancer Therapy DOI

Xu Wenting,

Ang Jia,

Zhixian Lei

et al.

European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 279, P. 116928 - 116928

Published: Sept. 30, 2024

Language: Английский

Citations

4

IR783‐Stabilized Nanodrugs Enhance Anticancer Immune Response by Synergizing Oxidation Therapy and Epigenetic Modulation DOI Creative Commons
Jinzhao Liu,

Meicen Wu,

Qingyang Lyu

et al.

Advanced Science, Journal Year: 2025, Volume and Issue: unknown

Published: March 27, 2025

Abstract Immune evasion and metastasis are the leading causes of poor prognosis in triple‐negative breast cancer treatment. Since current standard immunotherapies have limited efficacy due to immunologically cold microenvironment, it is crucial explore new strategies sensitize anticancer immune response. In this study, found that incorporating β ‐lapachone‐based oxidation therapy with CUDC101‐initiated epigenetic regulation results synergistic antitumor effects potent activation. To co‐deliver these two hydrophobic drugs, IR783 cyanine structure serves as stabilizer form a nanoformulation based on small molecule self‐assembly. Such IR783‐stabilized nanodrugs can not only lead cell apoptosis through HDAC inhibition‐enhanced but also cooperatively induce immunogenic death promote pro‐inflammatory cytokine gene expression reshape immunosuppressive microenvironment. Besides, inhibit both primary distant tumor growth effectively by elevating systemic immunity. This study provides promising approach synergize modulation for safe efficient immunotherapy.

Language: Английский

Citations

0

Selective activity of Tabebuia avellanedae against Giardia duodenalis infecting organoid-derived human gastrointestinal epithelia DOI Creative Commons
Giulia Rigamonti, Fabrizia Veronesi, Elisabetta Chiaradia

et al.

International Journal for Parasitology Drugs and Drug Resistance, Journal Year: 2025, Volume and Issue: 27, P. 100583 - 100583

Published: Jan. 23, 2025

Giardia duodenalis is a widespread intestinal protozoan that affects mammals, including humans. Symptoms can range from being subclinical to causing severe abdominal pain and diarrhoea. Giardiasis often requires repeated treatment with synthetic drugs like metronidazole. In recent years, failures in clinical cases involving nitroimidazoles have been increasingly reported. Consequently, identifying therapeutic alternatives necessary. Medicinal plants traditionally used as antiparasitic compounds, but systematic evaluation under controlled experimental conditions lacking. Here, we evaluated the vitro efficacy of Tabebuia avellanedae dry hydroalcoholic extracts, well one its active β-lapachone, potential against G. infection. We observed effective antigiardial activity for all tested β-lapachone exhibiting lower IC50 values than Cytotoxic effects limit concentration windows opportunity, choosing an informative model assess them not straightforward. present case, only T. extract showed no cytotoxicity on tumoral human Caco-2 cell line, trend inhibition when canine epithelial kidney MDCK cells. To introduce more physiological test system, infection experiments trans-well set-up using organoid derived monolayers (ODM) at same time drug parasite safety primary epithelia, likely surrogate vivo conditions. Our studies this point towards opportunity non-systemic applications extracts relevant ingredient these, β-lapachone. The data suggest ODM co-cultures are suitable testing providing before progressing tests.

Language: Английский

Citations

0

A photoswitchable phase-reversible gel engine for systemic redox homeostasis remodeling and on-demand chemodynamic immunotherapy with sustainable immunostimulation DOI
Minghao Sun, Weiwei Liu, Yuan‐Yuan Ma

et al.

Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: unknown, P. 160516 - 160516

Published: Feb. 1, 2025

Language: Английский

Citations

0

Micelle into gel thermosensitive intra-articular hydrogels for osteoarthritis management DOI
Helena Rouco, María Permuy, Fernando Muñóz

et al.

Journal of Controlled Release, Journal Year: 2025, Volume and Issue: unknown, P. 113639 - 113639

Published: March 1, 2025

Language: Английский

Citations

0

Engineering Magnetic Extracellular Vesicles Mimetics for Enhanced Targeting Chemodynamic Therapy to Overcome Ovary Cancer DOI
Shuai Wang,

Yinghua Mao,

Rong Shu

et al.

ACS Applied Materials & Interfaces, Journal Year: 2024, Volume and Issue: 16(30), P. 39021 - 39034

Published: July 21, 2024

Chemodynamic therapy (CDT), employing metal ions to transform endogenous H2O2 into lethal hydroxyl radicals (•OH), has emerged as an effective approach for tumor treatment. Yet, its efficacy is diminished by glutathione (GSH), commonly overexpressed in tumors. Herein, a breakthrough strategy involving extracellular vesicle (EV) mimetic nanovesicles (NVs) encapsulating iron oxide nanoparticles (IONPs) and β-Lapachone (Lapa) was developed amplify intracellular oxidative stress. The combination, NV-IONP-Lapa, created through serial extrusion from ovarian epithelial cells showed excellent biocompatibility leveraged magnetic guidance enhance endocytosis cancer cells, resulting selective generation Lapa catalysis NADPH quinone oxidoreductase 1 (NQO1). Meanwhile, the released IONPs ionization under acidic conditions triggered conversion of •OH Fenton reaction. Additionally, process eliminated GSH tumor, further amplifying designed NV-IONP-Lapa demonstrated exceptional targeting, facilitating MR imaging, enhanced suppression without significant side effects. This study presents promising NV-based drug delivery system exploiting CDT against NQO1-overexpressing tumors augmenting intratumoral

Language: Английский

Citations

2

SP600125, a selective JNK inhibitor, is a potent inhibitor of NAD(P)H: quinone oxidoreductase 1 (NQO1) DOI
Bingling Zhong, Yifei Zhang, Haoyi Zheng

et al.

Acta Pharmacologica Sinica, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 25, 2024

Language: Английский

Citations

2